BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24527881)

  • 1. Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice.
    Wu B; Meng K; Ji Q; Cheng M; Yu K; Zhao X; Tony H; Liu Y; Zhou Y; Chang C; Zhong Y; Zhu Z; Zhang W; Mao X; Zeng Q
    Clin Exp Immunol; 2014 Jun; 176(3):438-51. PubMed ID: 24527881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury.
    Cao Z; Hu Y; Wu W; Ha T; Kelley J; Deng C; Chen Q; Li C; Li J; Li Y
    Cardiovasc Res; 2009 Dec; 84(3):442-51. PubMed ID: 19586942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury.
    Venkatachalam K; Prabhu SD; Reddy VS; Boylston WH; Valente AJ; Chandrasekar B
    J Biol Chem; 2009 Mar; 284(12):7853-65. PubMed ID: 19164288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury.
    Carbone F; Crowe LA; Roth A; Burger F; Lenglet S; Braunersreuther V; Brandt KJ; Quercioli A; Mach F; Vallée JP; Montecucco F
    J Mol Cell Cardiol; 2016 May; 94():82-94. PubMed ID: 27056420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration.
    Liao YH; Xia N; Zhou SF; Tang TT; Yan XX; Lv BJ; Nie SF; Wang J; Iwakura Y; Xiao H; Yuan J; Jevallee H; Wei F; Shi GP; Cheng X
    J Am Coll Cardiol; 2012 Jan; 59(4):420-9. PubMed ID: 22261166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemerin15-Ameliorated Cardiac Ischemia-Reperfusion Injury Is Associated with the Induction of Alternatively Activated Macrophages.
    Chang C; Ji Q; Wu B; Yu K; Zeng Q; Xin S; Liu J; Zhou Y
    Mediators Inflamm; 2015; 2015():563951. PubMed ID: 26161004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-146a Mimic Inhibits NOX4/P38 Signalling to Ameliorate Mouse Myocardial Ischaemia Reperfusion (I/R) Injury.
    Xiao L; Gu Y; Ren G; Chen L; Liu L; Wang X; Gao L
    Oxid Med Cell Longev; 2021; 2021():6366254. PubMed ID: 34367463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury.
    Lu C; Ren D; Wang X; Ha T; Liu L; Lee EJ; Hu J; Kalbfleisch J; Gao X; Kao R; Williams D; Li C
    Biochim Biophys Acta; 2014 Jan; 1842(1):22-31. PubMed ID: 24140513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-2/Anti-IL-2 Complex Attenuates Cardiac Ischaemia-Reperfusion Injury Through Expansion of Regulatory T Cells.
    Xiao J; Yu K; Li M; Xiong C; Wei Y; Zeng Q
    Cell Physiol Biochem; 2017; 44(5):1810-1827. PubMed ID: 29224017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury.
    Qian W; Zhao C; Li D; Dai R
    Arch Cardiovasc Dis; 2018 Oct; 111(10):545-554. PubMed ID: 29724623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-21 promotes myocardial ischaemia/reperfusion injury through the modulation of neutrophil infiltration.
    Wang K; Wen S; Jiao J; Tang T; Zhao X; Zhang M; Lv B; Lu Y; Zhou X; Li J; Nie S; Liao Y; Wang Q; Tu X; Mallat Z; Xia N; Cheng X
    Br J Pharmacol; 2018 Apr; 175(8):1329-1343. PubMed ID: 28294304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin-7-
    Quan W; Ma S; Zhu Y; Shao Q; Hou J; Li X
    Pharm Biol; 2020 Dec; 58(1):80-88. PubMed ID: 31887257
    [No Abstract]   [Full Text] [Related]  

  • 13. Exogenous ubiquitin reduces inflammatory response and preserves myocardial function 3 days post-ischemia-reperfusion injury.
    Scofield SLC; Dalal S; Lim KA; Thrasher PR; Daniels CR; Peterson JM; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H617-H628. PubMed ID: 30681370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
    Bagchi AK; Akolkar G; Mandal S; Ayyappan P; Yang X; Singal PK
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1238-H1247. PubMed ID: 28432060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
    Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
    Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury.
    Altavilla D; Deodato B; Campo GM; Arlotta M; Miano M; Squadrito G; Saitta A; Cucinotta D; Ceccarelli S; Ferlito M; Tringali M; Minutoli L; Caputi AP; Squadrito F
    Cardiovasc Res; 2000 Aug; 47(3):515-28. PubMed ID: 10963724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DUSP14 knockout accelerates cardiac ischemia reperfusion (IR) injury through activating NF-κB and MAPKs signaling pathways modulated by ROS generation.
    Lin B; Xu J; Feng DG; Wang F; Wang JX; Zhao H
    Biochem Biophys Res Commun; 2018 Jun; 501(1):24-32. PubMed ID: 29660332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional deletion of cardiomyocyte peroxisome proliferator-activated receptor γ enhances myocardial ischemia-reperfusion injury in mice.
    Hobson MJ; Hake PW; O'Connor M; Schulte C; Moore V; James JM; Piraino G; Zingarelli B
    Shock; 2014 Jan; 41(1):40-7. PubMed ID: 24089001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-708 affords protective efficacy in anoxia/reoxygenation-stimulated cardiomyocytes by blocking the TLR4 signaling via targeting HMGB1.
    Zhang S; Wang Y; Wang P; Xuan J
    Mol Cell Probes; 2020 Dec; 54():101653. PubMed ID: 32866662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.